In a groundbreaking development, the U.S. Food and Drug Administration (FDA) has approved Journavx (suzetrigine), a novel non-opioid pain medication developed by Vertex Pharmaceuticals. This approval marks the first introduction of a new class of pain treatment in over two decades, offering a promising alternative for managing moderate to severe acute pain without the risks […]